Antidepressant failure: augmentation or substitution?
作者信息
Joffe R T, Levitt A J
出版信息
J Psychiatry Neurosci. 1995 Jan;20(1):7-9.
Abstract
摘要
相似文献
1
Antidepressant failure: augmentation or substitution?抗抑郁药治疗失败：增效还是换药？
J Psychiatry Neurosci. 1995 Jan;20(1):7-9.
2
Augmentation strategies in patients with refractory depression.难治性抑郁症患者的增效策略。
Depress Anxiety. 1996;4(4):169-81. doi: 10.1002/(SICI)1520-6394(1996)4:4<169::AID-DA3>3.0.CO;2-A.
3
[Therapy refractory depression].[难治性抑郁症]
Wien Med Wochenschr. 1999;149(18):511-4.
4
Treating antidepressant nonresponders with augmentation strategies: an overview.采用增效策略治疗抗抑郁药无反应者：综述
J Clin Psychiatry. 1998;59 Suppl 5:5-12; discussion 13-5.
5
Antidepressant combination and potentiation.
Psychiatr Med. 1991;9(1):55-75.
6
[Co-prescription with a given antidepressant: empirical or rational treatment?].
Encephale. 1995 Feb;21 Spec No 1:19-21.
7
[Cognitive effects of chronic antidepressant treatment].
Encephale. 1995 Feb;21 Spec No 1:15-8.
8
Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.溴隐亭治疗三环类和杂环类抗抑郁药难治性抑郁症。
Biol Psychiatry. 1996 Jul 15;40(2):151-3. doi: 10.1016/0006-3223(95)00666-4.
9
Combination pharmacotherapy in unipolar depression.单相抑郁症的联合药物治疗。
Expert Rev Neurother. 2006 Jul;6(7):1049-60. doi: 10.1586/14737175.6.7.1049.
10
The Pisa syndrome (pleurothotonus) during antidepressant therapy.抗抑郁治疗期间的匹萨综合征（侧弓反张）
Biol Psychiatry. 1997 Jan 15;41(2):234-6. doi: 10.1016/S0006-3223(96)00405-2.
引用本文的文献
1
Treatment-resistant depression: therapeutic trends, challenges, and future directions.难治性抑郁症：治疗趋势、挑战及未来方向
Patient Prefer Adherence. 2012;6:369-88. doi: 10.2147/PPA.S29716. Epub 2012 May 1.
2
The strategy of combining antidepressants in the treatment of major depression: clinical experience in spanish outpatients.联合使用抗抑郁药治疗重度抑郁症的策略：西班牙门诊患者的临床经验
Depress Res Treat. 2011;2011:140194. doi: 10.1155/2011/140194. Epub 2011 Jun 15.
3
Refractory depression: treatment strategies, with particular reference to the thyroid axis.难治性抑郁症：治疗策略，特别涉及甲状腺轴
J Psychiatry Neurosci. 1997 Nov;22(5):327-31.
本文引用的文献
1
A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.在单相难治性抑郁症中，锂盐和三碘甲状腺原氨酸增强三环类抗抑郁药作用的安慰剂对照比较。
Arch Gen Psychiatry. 1993 May;50(5):387-93. doi: 10.1001/archpsyc.1993.01820170065008.
2
Inhibition by fluoxetine of cytochrome P450 2D6 activity.氟西汀对细胞色素P450 2D6活性的抑制作用。
Clin Pharmacol Ther. 1993 Apr;53(4):401-9. doi: 10.1038/clpt.1993.43.
3
Combined SSRI-moclobemide treatment of psychiatric illness.选择性5-羟色胺再摄取抑制剂（SSRI）与吗氯贝胺联合治疗精神疾病。
J Clin Psychiatry. 1994 Jan;55(1):24-5.
4
Desipramine plasma concentration and antidepressant response.
Arch Gen Psychiatry. 1982 Dec;39(12):1419-22. doi: 10.1001/archpsyc.1982.04290120049010.
5
Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.在三环类抗抑郁药抵抗的单相抑郁中添加碳酸锂。与三环类抗抑郁药和锂离子对血清素系统的神经生物学作用的相关性。
Arch Gen Psychiatry. 1983 Dec;40(12):1327-34. doi: 10.1001/archpsyc.1983.01790110069012.
6
Characteristics of responders to fluoxetine.氟西汀反应者的特征。
Psychopharmacol Bull. 1984 Winter;20(1):70-2.
7
Tricyclic nonresponders: phenomenology and treatment.
Am J Psychiatry. 1986 Mar;143(3):345-8. doi: 10.1176/ajp.143.3.345.
8
A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.对氟西汀与丙咪嗪及安慰剂治疗重度抑郁症门诊患者的多中心对照研究的综述。
J Clin Psychiatry. 1985 Mar;46(3 Pt 2):53-8.
9
Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant.用单胺氧化酶抑制剂抗抑郁药治疗三环类难治性抑郁症。
Psychopharmacol Bull. 1987;23(1):169-72.
10
Study duration in antidepressant research: advantages of a 12-week trial.抗抑郁药物研究中的研究时长：12周试验的优势
J Psychiatr Res. 1986;20(3):211-6. doi: 10.1016/0022-3956(86)90004-x.
Zotero 插件